Immunome (IMNM)
(Delayed Data from NSDQ)
$15.29 USD
-0.21 (-1.35%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $15.28 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.60 |
EPS Last Quarter | -0.49 |
Last EPS Surprise | -28.95% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.18 |
Next Year | -3.04 |
EPS (TTM) | -1.73 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.60M | 5.11M | 7.65M | 8.27M |
# of Estimates | 2 | 2 | 4 | 1 |
High Estimate | 4.80M | 7.80M | 16.00M | 8.27M |
Low Estimate | 2.39M | 2.41M | 3.00M | 8.27M |
Year ago Sales | 3.57M | 3.83M | 14.02M | 7.65M |
Year over Year Growth Est. | 0.70% | 33.29% | -45.46% | 8.18% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.60 | -0.63 | -4.18 | -3.04 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | -0.65 | -0.66 | -4.21 | -3.68 |
High Estimate | -0.53 | -0.50 | -3.91 | -2.45 |
Low Estimate | -0.77 | -0.81 | -4.51 | -3.97 |
Year ago EPS | -0.36 | -0.54 | -1.31 | -4.18 |
Year over Year Growth Est. | -66.67% | -16.67% | -219.08% | 27.27% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 4 | 4 | 5 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.60 | -0.63 | -4.18 | -3.04 |
7 Days Ago | -0.60 | -0.63 | -4.18 | -3.04 |
30 Days Ago | -0.60 | -0.63 | -4.18 | -3.04 |
60 Days Ago | -0.42 | -0.47 | -3.66 | -2.72 |
90 Days Ago | -0.42 | -0.47 | -3.66 | -2.72 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.60 | -0.63 | -4.18 | -3.04 |
Zacks Consensus Estimate | -0.60 | -0.63 | -4.18 | -3.04 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.49 | -0.34 | -0.54 | -0.36 | NA |
Estimate | -0.38 | -0.80 | -0.28 | NA | NA |
Difference | -0.11 | 0.46 | -0.26 | NA | 0.03 |
Surprise | -28.95% | 57.50% | -92.86% | NA | -21.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more